Clinical trials for Imaging

Study title: Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28867

Study title: Open-label, multicenter trial of Magnevist® enteral in magnetic resonance imaging of patients

Active substance: GADOPENTETIC ACID

Study summary document link (including results): ME90095 ME91005 ME91006.pdf

View full study record

Document reference: 28825

Study title: A Prospective Blinded Read to Explore the Efficacy of MULTIHANCE and MAGNEVIST (0.10 mmol/kg) in Magnetic Resonance Imaging (MRI) of Brain and Spine Tumors in Pediatric Population

Active substance: FUSIDIC ACID

Study summary document link (including results):

View full study record

Document reference: 28722

Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children (6 to 12 years)

Active substance: GADOPENTETIC ACID

Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86238_study_synopsis.pdf

View full study record

Document reference: 28820

Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients, 16-18 years (phase III)

Active substance: GADOPENTETIC ACID

Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87191_study_synopsis.pdf

View full study record

Document reference: 28822

Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of brain lesions in children (2-6 years) (phase III).

Active substance: GADOPENTETIC ACID

Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87224_study_synopsis.pdf

View full study record

Document reference: 28823

Study title: Uncontrolled multicentre study for the further demonstration of the tolerance and efficacy of dimeglumine gadopentatate on intravenous use in magnetic resonance imaging in adults

Active substance: GADOPENTETIC ACID

Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86110_study_synopsis.pdf

View full study record

Document reference: 28816

Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST®(G d DTPA) 0.1 mmol/kg

Active substance: GADODIAMIDE

Study summary document link (including results): SW1357 Redacted.pdf

View full study record

Document reference: 47577

Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST® (Gd DTPA) 0.1 mmol/kg (Protocol 50678-005, Study B)

Active substance: GADODIAMIDE

Study summary document link (including results): SW1358 Redacted.pdf

View full study record

Document reference: 47578

Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Less Than 2 Years of Age by Intravenous Administration: An Open Label Study of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg

Active substance: GADODIAMIDE

Study summary document link (including results): SW1356 Redacted.pdf

View full study record

Document reference: 47576

Study title: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F.

Active substance: GADODIAMIDE

Study summary document link (including results):

View full study record

Document reference: 28808

Study title: J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL.

Active substance: GADODIAMIDE

Study summary document link (including results):

View full study record

Document reference: 28809

Study title: Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28871

Study title: Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28861

Study title: Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28868

Study title: Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28852

Study title: Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28840

Study title: Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28843

Study title: Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28850

Study title: Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28847

Study title: Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28866

Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients.

Active substance: FUSIDIC ACID

Study summary document link (including results):

View full study record

Document reference: 28721

Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients.

Active substance: GADOBENIC ACID

Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_B19036036.xls

View full study record

Document reference: 28800

Study title: Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW.

Active substance: GADODIAMIDE

Study summary document link (including results):

View full study record

Document reference: 28806

Study title: Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M.

Active substance: GADODIAMIDE

Study summary document link (including results):

View full study record

Document reference: 28805

Study title: Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28870

Study title: Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28865

Study title: Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28858

Study title: Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28849

Study title: Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265

Active substance: GADOTERIC ACID

Study summary document link (including results):

View full study record

Document reference: 28853

Study title: Sedation of children undergoing CT and MR imaging: the association of oral hydroxyzine and rectal chloral hydrate.

Active substance: HYDROXYZINE

Study summary document link (including results): ADPF97B1206.pdf

View full study record

Document reference: 29243

Study title: A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children.

Active substance: INDOMETHACIN

Study summary document link (including results):

View full study record

Document reference: 29804

Study title: Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I et al. A radiopharmaceuticals schedale for imaging in paediatrics. [piepsz-1990]Eur J Nucl Med 1990;17 : 127 – 129. Piepsz A 1990

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48690

Study title: Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al.. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. [pirotte-2006]J Neurosurg. 2006 Feb;104(2):238-53. Pirotte B 2006

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48691

Study title: Procedure Guideline for Tumor Imaging Using Fluorine- 1 8-FDGJ Nucl Med 1998; 3&13&1305. Heinrich R. Schelbert, Carl K. Hoh, Henry D. Royal, Manuel Brown, Magnus N. Dahlbom, Farrokh Dehdashti and Richard L. Wahl

Active substance: Steripet

Study summary document link (including results): schelbert-1998.pdf

View full study record

Document reference: 48744

Study title: Extravasation from venous catheter: a serious complication potentially missed by lung imaging.Spicer KM 1983 J Nucl Med. 1983Nov;24(11):1023-6.

Active substance: TECHNETIUM (99m)

Study summary document link (including results): Spicer 1983.pdf

View full study record

Document reference: 48788

Study title: Q Clinical impact of fluorine-18fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.JNucl Med Mol Imaging. 2006 Mar;50(1):68-77. Andrieux A 2006

Active substance: SteriPET

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48624

Study title: Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR.. Neuroimaging in infantile autism. [schifter-1994]J Child Neurol. 1994 Apr;9(2):155-61. Schifter T 1994

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48695

Study title: Bar-Shalom R, Gaitini D, Keidar Z, Israel O.. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. [bar-shalam-2004Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Bar-Shalom R 2004

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48628

Study title: Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, Arends B, Verzijlbergen FJ, Zijlstra J, Paans AM, Comans EF,. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. [boellaard-2008]Pruim J Eur J Nucl Med Mol Imaging 2008 12:2320–2333. Boellaard R 2008

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48633

Study title: Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al.. Increased fluorine-18 2-fluoro-2-deoxy-Dglucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. [borgwardt-2005]J Clin Oncol. 2005 May 1;23(13):3030-7. Borgwardt L 2005

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48634

Study title: Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, et al.. Epub 2006 Jan 11. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. [brenner-2006]Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. Brenner W 2006

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48635

Study title: Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570

Active substance: IOVERSOL

Study summary document link (including results):

View full study record

Document reference: 30399

Study title: Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children.Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. Pediatr Radiol 2008;38:841-7.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48583

Study title: Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agentsLopez-Longo FJ. Menard HA. Carreno L. eosin J. Ballesteros R. Monteagudo I. J Rheumatol 1987 Oct;14(5):991-4

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48499

Study title: Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26

Active substance: IOVERSOL

Study summary document link (including results):

View full study record

Document reference: 30404

Study title: Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al.. Epub 2005 Feb 15. [18F]3'-deoxy-3'- fluorothymidine PET for the diagnosis and grading of brain tumors. [choi-2005]Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Choi SJ 2005

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48637

Study title: Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosisUrso S, Pacciani E, Fariello G, Colajacomo M, Fassari FM, Randisi F, et al. Radiol Med 1995 Sep;90(3):212-8

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48763

Study title: Radionuclide imaging in bilateral os trigonum syndrome in a young athlete. Minoves M, Company A, Ardevol J, Matas RB, Costansa JM, Setoain J, Domenech-Torné FM. Clin Nucl Med. 2001 Mar;26(3):237-8. No abstract available.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 43458

Study title: Radionuclide imaging in the evaluation of osteomyelitis and septic arthritis.Kim EE, Haynie TP, Lowry PA, Harle TS. Crit Rev Diagn Imaging 1989; 29(3):257-305

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48751

Study title: Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient ManagementRachel Bar-Shalom, MD1; Nikolai Yefremov, MD1; Ludmila Guralnik, MD2; Diana Gaitini, MD2,3; Alex Frenkel, DSc1; Abraham Kuten, MD3,4; Hernan Altman, MBA5; Zohar Keidar, MD, PhD1; and Ora Israel, MD1,3. THE JOURNAL OF NUCLEAR MEDICINE • Vol. 44 • No. 8 • August 2003

Active substance: Steripet

Study summary document link (including results): bar-shalom-2003.pdf

View full study record

Document reference: 48623

Study title: Early Irradiation Effects Observed on Magnetic Resonance Imaging and Angiography, and Positron Emission Tomography for Arteriovenous Malformations Treated by Gamma Knife Radiosurgery. Stereotact Funct Neurosurg 1995;61(suppl1):25S-269. 1VY Glio? D.H.C. Pollb, R.S. Lilic, 1VY Cll~i~lCg.Y~ ,S llio1~~, S.S. Cllalgc, C.Y Cllo~lgK~;,Y CIze~zS~.,H . Yellc, L.S. Leeb

Active substance: Steripet

Study summary document link (including results): guo-1994.pdf

View full study record

Document reference: 48730

Study title: Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant LymphomaJ Nucl Med 2001; 42:1139–1143. Heiko Scho¨der, Joubin Meta, Cecilia Yap, Maryam Ariannejad, Jyotsna Rao, Michael E. Phelps, Peter E. Valk, Jim Sayre, and Johannes Czernin

Active substance: Steripet

Study summary document link (including results): schoder-2001.pdf

View full study record

Document reference: 48745

Study title: Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500. Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 44093

Study title: Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N.

Active substance: THALLIUM 201T1 CHLORIDE

Study summary document link (including results):

View full study record

Document reference: 44556

Study title: Thallium-201 scintigraphy in childhood osteosarcoma: Comparison with Technituim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.Ilhan IE, Gulin V, Berberoglu S, Kapucuoglu N, Cila A, Eke S. Quantitative Hematol Oncol 2005;22(2):153-62

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48725

Study title: Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jurgens H, et al.. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. [franzius-2002]Franzius C 2002. Ann Oncol. 2002 Jan;13(1):157-60

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48645

Study title: Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, et al.. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. [furth-2006]J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Furth C 2006

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48652

Study title: The suspected scaphoid fracture and isotope bone imaging. Brown JN. Injury. 1995 Sep;26(7):479-82.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48836

Study title: The suspected scaphoid fracture and isotope bone imaging.Brown JN. Injury 1995 Sep;26(7):479-82.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48582

Study title: Three-phase radionuclide bone imaging in stress injury of the anterior iliac crestRockett JF. J Nucl Med 1990 Sep;31(9):1554-6

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48512

Study title: Use of 99m-Tc-MDP Spect for assessment of mandibular growth: development of normal values.Fahey FH, Abramson ZR, Padwa BL, Zimmerman RE, Zurakowski D, Nissenbaum M, et al. Eur J Nucl Med Mol Imaging 2010;37:1002-10.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48722

Study title: Uterine blush in multiphase bone imaging.Mandell GA. Harcke HT. Sharkey C. Brooks K. J Nucl Med 1986a Jan;27(1):51-5

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48503

Study title: Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography.Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography.

Active substance: Perflutren

Study summary document link (including results):

View full study record

Document reference: 41585

Study title: Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. Stauss J, Hahn K, Mann M, De Palma D. Eur J Nucl Med Mol Imaging. (8 pages) Published online: www.eanm.org/scientific_info/guidelines/EJNMMI_Bone_Scintigraphy_in_Children.pdf

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48759

Study title: Chapter 7: Radionuclide techniques. In: Resnick D and Kransdorf MJ eds. Bone and joint imaging. 3rd Ed. Philidelphia. PA.Schneider R. Elsevier Saunders; 2005:86-117

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48515

Study title: Gaillard WD. Ment Retard Dev Disabil Res. Structural and functional imaging in children with partial epilepsy. [gaillard-2000]Rev. 2000;6(3):220-6. Gaillard WD 2000

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48654

Study title: Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU.. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? [hoegerle 1998]Radiology. 1998 Oct;209(1):253-8. Hoegerle S 1998

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48658

Study title: Holm S, Borgwardt L, Loft A, Graff J, Law I, Højgaard L. Paediatric doses – a critical appraisal of the EANM paediatric dosage card. [holm-2007]Eur J Nucl Med Mol Imaging 2007; 34 : 1713 - 1718. Holm S 2007

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48659

Study title: Hudson MM, Krasin MJ, Kaste SC.. Epub 2004 Jan 27. PET imaging in pediatric Hodgkin's lymphoma. [hudson-2004]Pediatr Radiol. 2004 Mar;34(3):190-8. Hudson MM 2004

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48660

Study title: Imaging the epileptic brain with positron emission tomography.Neuroimag Clin N Am 13 (2003) 705– 716. Csaba Juha´sz, MD, PhDa,b,*, Harry T. Chugani, MDa,b

Active substance: Steripet

Study summary document link (including results): juhasz-2003.pdf

View full study record

Document reference: 48733

Study title: Jacobs F, Thierens H, Piepsz A, Bacher K, van de Wiele C, Ham H et al. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. [jacobs 2005Eur J Nucl Med Mol Imaging 2005; 32 : 581 - 588. Jacobs F 2005

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48662

Study title: Jasper N, Däbritz J, Frosch M, Loeffler M, Weckesser M, Foell D.. Epub. Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. [jasper-2010] Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):136-45. Jasper N 2010

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48663

Study title: Cherubism: diagnostic imaging and review of the literature in JapanHitomi G. Nishide N. Mitsui K. Ora l Surg Oral Med Oral Pathol Oral Radial Endod 1996 May;81(5):623-8

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48487

Study title: Tc-99m MAA total-body imaging to detect intrapulmonary right-to-left shunts and to evaluate the therapeutic effect in pulmonary arteriovenous shunts. Clin Nucl Med. 1996 Mar;21(3):197-202. Lu G 1996

Active substance: TECHNETIUM (99m)

Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc

View full study record

Document reference: 48815

Study title: Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. Buck FM, Treumann TC, Winiker H, Strobel K. J Magn Reson Imaging. 2007 Aug;26(2):422-6.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48837

Study title: Hematogenous pyogenic vertebral osteomyelitis: diagnostic value of radionuclide bone imaging.Adatepe MH, Powell OM, Isaacs GH, Nichols K, Cefola R. J Nucl Med 1986 Nov;27(11):1680-5.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48523

Study title: (99m)Tc-MDP scintigraphic findings in children with leukemia: value of early and delayed whole-body imagingShalaby-Rana E, Majd M. J Nucl Med 2001 Jun;42(6):878-83

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48514

Study title: "Cold spots" in pediatric bone imagingRosovsky M. Goldfarb CR. Finestone H. Ongseng F. Semin Nucl Med 1994 Apr;24(2):184-6

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48513

Study title: Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, et al.. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. [kamel-2002]Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. Kamel E 2002

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48665

Study title: Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, EANM Dosimetry and Paediatrics Committees.. The new EANM paediatric dosage card. [lassman-2007]Eur J Nucl Med Mol Imaging 2007; 34:796–798. Lassmann M 2007

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48673

Study title: Comparison of bone and gallium-67 imaging in heroin users' arthritis.Bittini A, Dominguez PL, Martinez Pueyo ML, López Longo FJ, Monteagudo I, Carreño L. J Nucl Med 1985 Dec;26(12):1377-81.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48572

Study title: Hematogenous Pyogenic Vertebral Osteomyelitis:Diagnostic Value of Radionucide Bone ImagingMustafa H. Adatepe, Oscar M. Powell, Gilbert H. Isaacs, Kenneth Nichols, and Raymond Cefola. J Nucl Med 27:1680-1685, 1986

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48832

Study title: I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.Englaro EE, Gelfand MJ, Harris RE, Smith HS. Radiology 1992 182(2):515-20

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48721

Study title: Increased activity on immediate phase of bone imaging does not always indicate increased blood volume.Webster DL, Hurwitz GA, DeVeber LL, Troster M, Driedger AA. Clin Nucl Med 1986 Nov;11(11):749-50

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48764

Study title: Bandopadhyaya G. Malhotra A. Soft tissue uptake of Tc99m-MDP in acute lymphoblastic leukemia.Marwah A. Kumar R. Dasan J B. Choudhury S. Bandopadhyaya G. Malhotra A. Cl in Imaging 2002 May-Jun;26(3):206-8

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48505

Study title: Correlation of diagnostic imaging and subsequent autopsy findings in patients with pulmonary embolism. Patriquin L, Khorasani R, Polak JF. AJR Am J Roentgenol. 1998 Aug;171(2):347-9 Comment in: AJR Am J Roentgenol. 1998 Aug;171(2):293. AJR Am J Roentgenol. 1999 Jun;172(6):1691-3.

Active substance: TECHNETIUM (99m)

Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc

View full study record

Document reference: 48244

Study title: McCarville MB.. Review. PET-CT imaging in pediatric oncology. [mccarville-2009]Cancer Imaging. 2009 Jun 29;9:35-43. McCarville MB 2009

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48676

Study title: Mody RJ, Bui C, Hutchinson RJ, Yanik GA, Castle VP, Frey KA, Shulkin BL.. FDG PET imaging of childhood sarcomas. [mody-2010]Pediatr Blood Cancer. 2010 Feb;54(2):222-7. Mody RJ 2010

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48678

Study title: Bone imaging for lower extremity pain in athletes.Brill DR. Clin Nucl Med 1983 Mar;8(3):101-6.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 48579

Study title: Naumann R, Beuthien-Baumann B, Reiß A, Schulze J, Hänel A, Bredow J, et al.. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. [naumann-2004]BrJ Cancer. 2004 Feb 9;90(3):620-5. Naumann R 2004

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48682

Study title: Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, et al.. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. [ng-2004-a]Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Ng SH 2004

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48684

Study title: Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC.. Epub 2005 Aug 31. Respiratory motion artefact n the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. [papathanassiou-2005]Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Papathanassiou D 2005

Active substance: Steripet

Study summary document link (including results): 2011-09 GE response Template List of published articles.doc

View full study record

Document reference: 48688

Study title: Smith MA, Jones EA, Strachan RK, Nicoll JJ, Best JJ, Tothill P, Hughes SP. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. J Bone Joint Surg Br. 1987 May;69(3):441-7. Smith MA, Jones EA, Strachan RK, Nicoll JJ, Best JJ, Tothill P, Hughes SP. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. J Bone Joint Surg Br. 1987 May;69(3):441-7.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 43863

Study title: Sommer HJ, Knop J, Heise U, Winkler K, Delling G. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging. Cancer. 1987 Jan 15;59(2):252-8. Sommer HJ, Knop J, Heise U, Winkler K, Delling G. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging. Cancer. 1987 Jan 15;59(2):252-8.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 43876

Study title: Magill HL, Strang MS. Paraspinal metastasis of Wilm's tumor visualized on bone imaging. J Nucl Med. 1981 May;22(5):481-2. No abstract available. Magill HL, Strang MS. Paraspinal metastasis of Wilm's tumor visualized on bone imaging. J Nucl Med. 1981 May;22(5):481-2. No abstract available.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 44126

Study title: Raymond J, Dumas JM, Lisbona R. Nuclear imaging as a screening test for patients referred for intraarticular facet block. J Can Assoc Radiol. 1984 Sep;35(3):291-2. Raymond J, Dumas JM, Lisbona R. Nuclear imaging as a screening test for patients referred for intraarticular facet block. J Can Assoc Radiol. 1984 Sep;35(3):291-2.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 43984

Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 44228

Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 44275

Study title: A follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma. Ikekubo K, Habuchi Y, Jeong S, Yamaguchi H, Saiki Y, Ito H, Hino M, Higa T. Clin Nucl Med. 1986 Nov;11(11):777-80.

Active substance: TECHNETIUM (99mTc) MEDRONIC ACID

Study summary document link (including results):

View full study record

Document reference: 43888